Literature DB >> 7698084

Interactions of ingested food, beverage, and tobacco components involving human cytochrome P4501A2, 2A6, 2E1, and 3A4 enzymes.

F P Guengerich1, T Shimada, C H Yun, H Yamazaki, K D Raney, R Thier, B Coles, T M Harris.   

Abstract

Human cytochrome P450 (P450) enzymes are involved in the oxidation of natural products found in foods, beverages, and tobacco products and their catalytic activities can also be modulated by components of the materials. The microsomal activation of aflatoxin B1 to the exo-8,9-epoxide is stimulated by flavone and 7,8-benzoflavone, and attenuated by the flavonoid naringenin, a major component of grapefruit. P4502E1 has been demonstrated to play a potentially major role in the activation of a number of very low-molecular weight cancer suspects, including ethyl carbamate (urethan), which is present in alcoholic beverages and particularly stone brandies. The enzyme (P4502E1) is also known to be inducible by ethanol. Tobacco contains a large number of potential carcinogens. In human liver microsomes a significant role for P4501A2 can be demonstrated in the activation of cigarette smoke condensate. Some of the genotoxicity may be due to arylamines. P4501A2 is also inhibited by components of crude cigarette smoke condensate. The tobacco-specific nitrosamines are activated by a number of P450 enzymes. Of those known to be present in human liver, P4501A2, 2A6, and 2E1 can activate these nitrosamines to genotoxic products.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7698084      PMCID: PMC1566791          DOI: 10.1289/ehp.94102s949

Source DB:  PubMed          Journal:  Environ Health Perspect        ISSN: 0091-6765            Impact factor:   9.031


  31 in total

Review 1.  Cytochrome P450IIE1: roles in nitrosamine metabolism and mechanisms of regulation.

Authors:  C S Yang; J S Yoo; H Ishizaki; J Y Hong
Journal:  Drug Metab Rev       Date:  1990       Impact factor: 4.518

Review 2.  Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes.

Authors:  F P Guengerich; T Shimada
Journal:  Chem Res Toxicol       Date:  1991 Jul-Aug       Impact factor: 3.739

3.  Alcohol mixed function. Oxidase activity of mammalian liver microsomes.

Authors:  W H Orme-Johnson; D M Ziegler
Journal:  Biochem Biophys Res Commun       Date:  1965-10-08       Impact factor: 3.575

4.  Hepatic microsomal ethanol-oxidizing system. In vitro characteristics and adaptive properties in vivo.

Authors:  C S Lieber; L M DeCarli
Journal:  J Biol Chem       Date:  1970-05-25       Impact factor: 5.157

Review 5.  Induction of microsomal enzymes by foreign chemicals and carcinogenesis by polycyclic aromatic hydrocarbons: G. H. A. Clowes Memorial Lecture.

Authors:  A H Conney
Journal:  Cancer Res       Date:  1982-12       Impact factor: 12.701

6.  Vinyl carbamate as a promutagen and a more carcinogenic analog of ethyl carbamate.

Authors:  G A Dahl; J A Miller; E C Miller
Journal:  Cancer Res       Date:  1978-11       Impact factor: 12.701

7.  Activation and inhibition of benzo(a)pyrene and aflatoxin B1 metabolism in human liver microsomes by naturally occurring flavonoids.

Authors:  M K Buening; R L Chang; M T Huang; J G Fortner; A W Wood; A H Conney
Journal:  Cancer Res       Date:  1981-01       Impact factor: 12.701

8.  Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules.

Authors:  E C Miller; J A Miller
Journal:  Cancer       Date:  1981-05-15       Impact factor: 6.860

9.  Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomes.

Authors:  H Yamazaki; Y Inui; C H Yun; F P Guengerich; T Shimada
Journal:  Carcinogenesis       Date:  1992-10       Impact factor: 4.944

10.  Epidemiological correlations between diet and cancer frequency.

Authors:  P Correa
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

View more
  11 in total

Review 1.  Evaluation of in vitro assays for assessing the toxicity of cigarette smoke and smokeless tobacco.

Authors:  Michael D Johnson; Jodi Schilz; Mirjana V Djordjevic; Jerry R Rice; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

2.  CYP1A2, GSTM1, and GSTT1 polymorphisms and diet effects on CYP1A2 activity in a crossover feeding trial.

Authors:  Sabrina Peterson; Yvonne Schwarz; Shuying S Li; Lin Li; Irena B King; Chu Chen; David L Eaton; John D Potter; Johanna W Lampe
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-10-20       Impact factor: 4.254

3.  Age-related changes in the mRNA levels of CYP1A1, CYP2B1/2 and CYP3A1 isoforms in rat small intestine.

Authors:  Artur Pałasz; Anna Wiaderkiewicz; Ryszard Wiaderkiewicz; Piotr Czekaj; Beata Czajkowska; Tomasz Lebda-Wyborny; Aneta Piwowarczyk; Aleksandra Bryzek
Journal:  Genes Nutr       Date:  2011-07-17       Impact factor: 5.523

Review 4.  Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions.

Authors:  R J Bertz; G R Granneman
Journal:  Clin Pharmacokinet       Date:  1997-03       Impact factor: 6.447

5.  Silibinin inhibits ethanol metabolism and ethanol-dependent cell proliferation in an in vitro model of hepatocellular carcinoma.

Authors:  Elizabeth Brandon-Warner; James A Sugg; Laura W Schrum; Iain H McKillop
Journal:  Cancer Lett       Date:  2009-11-08       Impact factor: 8.679

Review 6.  Metabolism of drugs by cytochrome P450 3A isoforms. Implications for drug interactions in psychopharmacology.

Authors:  L L von Moltke; D J Greenblatt; J Schmider; J S Harmatz; R I Shader
Journal:  Clin Pharmacokinet       Date:  1995       Impact factor: 6.447

7.  Multiple-approaches to the identification and quantification of cytochromes P450 in human liver tissue by mass spectrometry.

Authors:  Cathrin Seibert; Brian R Davidson; Barry J Fuller; Laurence H Patterson; William J Griffiths; Yuqin Wang
Journal:  J Proteome Res       Date:  2009-04       Impact factor: 4.466

8.  Phenotypic CYP2A6 variation and the risk of pancreatic cancer.

Authors:  Susan Kadlubar; Jeffrey P Anderson; Carol Sweeney; Myron D Gross; Nicholas P Lang; Fred F Kadlubar; Kristin E Anderson
Journal:  JOP       Date:  2009-05-18

9.  Roles of alcohol and tobacco exposure in the development of hepatocellular carcinoma.

Authors:  Vishnudutt Purohit; Rao Rapaka; Oh Sang Kwon; B J Song
Journal:  Life Sci       Date:  2012-10-30       Impact factor: 5.037

10.  Toxicological aspects of the use of phenolic compounds in disease prevention.

Authors:  Zuzana Kyselova
Journal:  Interdiscip Toxicol       Date:  2011-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.